Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Resolving the ductal carcinoma in situ treatment conundrum.

Berg CD.

J Natl Cancer Inst. 2013 May 15;105(10):680-1. doi: 10.1093/jnci/djt097. No abstract available.

2.

A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ.

Duggal S, Julian TB.

J Natl Cancer Inst. 2013 May 15;105(10):681-3. doi: 10.1093/jnci/djt098. No abstract available.

3.

Ductal carcinoma in situ: through a glass, darkly.

Lagios MD, Silverstein MJ.

Ann Surg Oncol. 2008 Jan;15(1):16-7. No abstract available.

PMID:
18043977
4.

Significance of HER2 protein examination in ductal carcinoma in situ.

Horimoto Y, Tokuda E, Arakawa A, Kosaka T, Saito M, Kasumi F.

J Surg Res. 2011 May 15;167(2):e205-10. doi: 10.1016/j.jss.2009.07.030.

PMID:
20018297
5.

Ductal carcinoma in situ: a rose by any other name.

Wickerham DL, Julian TB.

J Natl Cancer Inst. 2013 Oct 16;105(20):1521-2. doi: 10.1093/jnci/djt268. No abstract available.

6.

Biomarkers predicting recurrence and progression of ductal carcinoma in situ treated by lumpectomy alone.

Allred DC.

J Natl Cancer Inst. 2010 May 5;102(9):585-7. doi: 10.1093/jnci/djq118. No abstract available.

7.

[Diabetes insipidus as the initial manifestation of breast carcinoma recurrence].

López Guzmán A, Herranz de la Morena L, Luna Cano R, Megía Colet A.

Rev Clin Esp. 1990 Sep;187(4):205-6. Spanish. No abstract available.

PMID:
1965336
8.

DCIS prognostic markers: a few new candidates emerge.

Nelson NJ.

J Natl Cancer Inst. 2010 May 5;102(9):588-90. doi: 10.1093/jnci/djq161. No abstract available.

9.

A useful immunohistochemical approach to evaluate intraductal proliferative lesions of the breast and to predict their prognosis.

Omi Y, Yamamoto T, Okamoto T, Obara T, Kobayashi M.

Histol Histopathol. 2011 Jan;26(1):79-86.

PMID:
21117029
10.

Challenges to interpretation of breast MRI.

Kinkel K, Hylton NM.

J Magn Reson Imaging. 2001 Jun;13(6):821-9. Review.

PMID:
11382939
11.

The Consensus Conference on the treatment of in situ ductal carcinoma of the breast, April 22-25, 1999.

Schwartz GF, Solin LJ, Olivotto IA, Ernster VL, Pressman PI.

Hum Pathol. 2000 Feb;31(2):131-9. Review. No abstract available.

PMID:
10685626
12.

Ductal carcinoma in situ of the breast: influence of age on diagnostic, therapeutic, and prognostic features. Retrospective study of 812 patients.

Tunon-de-Lara C, André G, Macgrogan G, Dilhuydy JM, Bussières JE, Debled M, Mauriac L, Brouste V, de Mascarel I, Avril A.

Ann Surg Oncol. 2011 May;18(5):1372-9. doi: 10.1245/s10434-010-1441-1.

PMID:
21108045
13.

Cystic hypersecretory carcinoma: rare and poorly recognized variant of intraductal carcinoma of the breast. Report of five cases.

Skalova A, Ryska A, Kajo K, Di Palma S, Kinkor Z, Michal M.

Histopathology. 2005 Jan;46(1):43-9. Review.

PMID:
15656885
14.

Expression of HER2neu in ductal carcinoma in situ is associated with local recurrence.

Han K, Nofech-Mozes S, Narod S, Hanna W, Vesprini D, Saskin R, Taylor C, Kong I, Paszat L, Rakovitch E.

Clin Oncol (R Coll Radiol). 2012 Apr;24(3):183-9. doi: 10.1016/j.clon.2011.09.008.

PMID:
21958729
15.

Follow-up care of patients with breast cancer.

Tolaney SM, Winer EP.

Breast. 2007 Dec;16 Suppl 2:S45-50. Review.

PMID:
17697780
16.

Recurrent ductal carcinoma in situ after total mastectomy.

Clark L, Ritter E, Glazebrook K, Tyler D.

J Surg Oncol. 1999 Jul;71(3):182-5. Review.

PMID:
10404135
17.

D2-40 expression by breast myoepithelium: potential pitfalls in distinguishing intralymphatic carcinoma from in situ carcinoma.

Rabban JT, Chen YY.

Hum Pathol. 2008 Feb;39(2):175-83. doi: 10.1016/j.humpath.2007.06.018.

PMID:
18206495
18.

Long-term follow-up study of a prospective multicenter sentinel node trial: molecular detection of breast cancer sentinel node metastases.

Verbanac KM, Min CJ, Mannie AE, Lu J, O'Brien KF, Rosman M, Tafra L; ECU/AAMC Sentinel Node Study Group..

Ann Surg Oncol. 2010 Oct;17 Suppl 3:368-77. doi: 10.1245/s10434-010-1262-2.

PMID:
20853060
19.

Ductal carcinoma in situ (DCIS) of the breast: diagnostic and therapeutic controversies.

Silverstein MJ, Parker R, Grotting JC, Cote RJ, Russell CA.

J Am Coll Surg. 2001 Feb;192(2):196-214. No abstract available.

PMID:
11220720
20.
Items per page

Supplemental Content

Support Center